Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
130.2 USD | -0.74% | +2.63% | +19.50% |
04:14pm | Merck Reports Positive Data for Investigational 21-Valent Pneumococcal Vaccine | MT |
08:52am | Blackstone beats Concord with $1.6 bln bid for Hipgnosis Songs | RE |
Financials (USD)
Sales 2024 * | 64.05B | Sales 2025 * | 68.54B | Capitalization | 332B |
---|---|---|---|---|---|
Net income 2024 * | 19.44B | Net income 2025 * | 22.05B | EV / Sales 2024 * | 5.48 x |
Net Debt 2024 * | 18.89B | Net Debt 2025 * | 7.52B | EV / Sales 2025 * | 4.96 x |
P/E ratio 2024 * |
16.9
x | P/E ratio 2025 * |
14.7
x | Employees | 71,000 |
Yield 2024 * |
2.33% | Yield 2025 * |
2.46% | Free-Float | 70.75% |
Latest transcript on Merck & Co., Inc.
1 day | +0.25% | ||
1 week | +3.39% | ||
Current month | -0.53% | ||
1 month | +0.19% | ||
3 months | +8.22% | ||
6 months | +27.82% | ||
Current year | +20.39% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Davis
CEO | Chief Executive Officer | 57 | 14-03-31 |
Director of Finance/CFO | 55 | 89-12-31 | |
Dave Williams
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tom Glocer
BRD | Director/Board Member | 63 | 07-11-26 |
Pamela Craig
BRD | Director/Board Member | 67 | 15-08-31 |
Inge Thulin
BRD | Director/Board Member | 69 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.34% | 215 M€ | +10.62% | - | |
5.61% | 18 M€ | +3.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 130.2 | -0.75% | 2 895 369 |
24-04-26 | 131.2 | +0.37% | 7,758,230 |
24-04-25 | 130.7 | +2.93% | 12,750,052 |
24-04-24 | 127 | +0.09% | 7,128,300 |
24-04-23 | 126.9 | -0.05% | 7,743,961 |
Delayed Quote Nyse, April 29, 2024 at 10:18 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.39% | 332B | |
+26.77% | 661B | |
+27.43% | 566B | |
-6.29% | 352B | |
+3.11% | 283B | |
+13.96% | 231B | |
+5.16% | 200B | |
-9.04% | 195B | |
-4.91% | 145B | |
-10.63% | 144B |
- Stock Market
- Equities
- MRK Stock